Accelerating Decisions with Epidemiology When Uncertainty Limits Development Confidence

• Identifying the right patient populations and geographies early to reduce uncertainty and enable faster, more confident clinical trial decisions
• Exploring how epidemiology and real-world evidence can support expansion beyond initial indications to unlock broader patient access and long term value
• Helping leadership make confident investment decisions by translating epidemiological insight into clear, decision‑relevant evidence that reduces risk and accelerates alignment

Speakers:

Colin Kunzweiler

Director - Infectious Disease Epidemiology

Moderna